Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 20 September 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Krsnaa Diagnostics Ltd witnessed a robust start to trading on 17 September 2026, opening with a significant gap up of 5.62% amid positive market sentiment. The stock outperformed its sector and broader indices, signalling renewed momentum after a brief period of decline.

Krsnaa Diagnostics Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite some mildly bullish signals on weekly MACD and KST, the overall technical landscape remains challenging, reflecting the stock’s underperformance relative to the broader market and its small-cap status within the healthcare services sector.

Krsnaa Diagnostics Ltd, a small-cap player in the healthcare services sector, has exhibited a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend. Despite a 2.42% gain on 10 Sep 2026, the stock’s broader technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, reflecting cautious investor sentiment amid ongoing market challenges.

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 September 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.

Krsnaa Diagnostics Ltd, a small-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from a Strong Sell to a Sell rating reflects deteriorating market sentiment, compounded by a 2.8% decline in its share price on 9 September 2026, closing at ₹547.15.

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 August 2026, providing investors with an up-to-date view of its performance and outlook.

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 15 August 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Krsnaa Diagnostics Ltd has reported a challenging quarter ending June 2026, marked by a notable shift from a flat to a negative financial trend. Despite achieving record net sales and robust PAT growth over the last six months, the company’s quarterly profitability and leverage metrics have raised concerns, prompting a downgrade in its Mojo Grade to Sell from Strong Sell.

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 04 August 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Krsnaa Diagnostics Ltd, a small-cap player in the Healthcare Services sector, has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend. Despite a modest day gain of 2.81%, the stock’s broader technical indicators reveal a complex picture of mixed signals, underscoring the challenges faced by investors amid a prolonged downtrend and sector headwinds.

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis below reflects the stock’s current position as of 24 July 2026, incorporating the latest fundamentals, returns, and financial metrics to provide investors with an up-to-date perspective.

Krsnaa Diagnostics Ltd, a small-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a more pronounced bearish trend. Despite some mildly bullish weekly signals, the overall technical indicators suggest increasing downward pressure on the stock, reflected in its recent price performance and technical grades.

Krsnaa Diagnostics Ltd has exhibited a nuanced shift in its technical momentum, moving from a predominantly bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a modest day gain of 1.70%, the stock’s broader trend remains cautious as key momentum oscillators and moving averages signal mixed sentiments for investors navigating the healthcare services sector.

Krsnaa Diagnostics Ltd, a small-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite some mildly bullish signals on shorter timeframes, the overall technical indicators suggest caution for investors as the stock continues to underperform relative to broader market benchmarks.

Krsnaa Diagnostics Ltd has exhibited a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a modest day gain of 0.60%, the stock’s broader trend remains cautious as key metrics such as MACD, RSI, and moving averages present a mixed picture for investors navigating the healthcare services sector.

Krsnaa Diagnostics Ltd, a small-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish trend. Despite some mildly bullish signals on weekly MACD and KST indicators, the overall technical landscape remains subdued, reflecting the stock’s challenging performance relative to broader market benchmarks.

Krsnaa Diagnostics Ltd, a small-cap player in the healthcare services sector, has exhibited a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a modest day gain of 1.26%, the stock’s broader technical indicators present a complex picture, reflecting mixed signals that investors should carefully analyse amid ongoing market volatility.